Tirzepatide News | Live Feed & Top Stories

In the last hour
 MailOnline21:01
In the last 8 hours
 Money Morning15:36
 WHDH-TV, Massachusetts15:27
 Yahoo! US15:26
Earlier today
 MailOnline12:49
 Quartz12:16
 24/7 Wall St.11:56
 CBS News11:43
 WIRED11:02
 Gibraltar Broadcasting Corporation06:36
 Toronto Star05:12
 The Diabetes Times04:43
Yesterday
 WOWT23:09 20-Feb-25
 Drug Topics15:35 20-Feb-25
 Business Wire (Press Release)14:09 20-Feb-25
 YaleNews12:32 20-Feb-25
 MailOnline11:22 20-Feb-25
 Wigan Today10:50 20-Feb-25
 Pharmaceutical Technology09:27 20-Feb-25
 GlobeNewswire (Press Release)08:33 20-Feb-25
 Clinical Trials Arena04:29 20-Feb-25
In the last 7 days
 TCTMD17:09 19-Feb-25
 South Carolina Attorney General (Press Release)16:07 19-Feb-25
 Oprah Daily13:06 19-Feb-25
 Macon.com12:19 19-Feb-25
 Bloomberg Law11:34 19-Feb-25
 24/7 Wall St.09:44 19-Feb-25
 The Seattle Times09:32 19-Feb-25
 Pharmaceutical Technology09:13 19-Feb-25
 News-Medical.Net07:04 19-Feb-25
 GlobeNewswire (Press Release)18:31 18-Feb-25
 Luxury Travel News13:45 18-Feb-25
 BBC01:31 18-Feb-25
 Somerset Live00:54 18-Feb-25
 ZME Science17:45 17-Feb-25
 NPR12:16 17-Feb-25
 Pharmacy Times11:07 17-Feb-25
 The Mirror06:15 17-Feb-25
 Wales Online03:19 17-Feb-25
 Drug Target Review10:57 16-Feb-25
 Knowridge Science Report06:09 15-Feb-25
 Fox News17:37 14-Feb-25
 HealthDay17:27 14-Feb-25
 Futurism09:34 14-Feb-25
 Verdict Medical Devices06:41 14-Feb-25
 The Financial Express01:43 14-Feb-25
In the last month
 Greek Reporter22:34 13-Feb-25
 The Financial Express20:42 13-Feb-25
 Knowridge Science Report20:06 13-Feb-25
 Yahoo! US15:42 13-Feb-25
 Drug Topics15:03 13-Feb-25
 Pharmaceutical Technology14:07 13-Feb-25
 HumanProgress13:49 13-Feb-25
 Longevity Technology13:22 13-Feb-25
 Good Housekeeping11:01 13-Feb-25
 Prevention.com08:03 13-Feb-25
 PR Newswire (Press Release)07:32 13-Feb-25
 PMLiVE07:23 13-Feb-25
 Zacks07:03 13-Feb-25
 pharmaphorum05:58 13-Feb-25
 The Motley Fool04:34 13-Feb-25
 Hindustan Times03:00 13-Feb-25
 9News20:49 12-Feb-25
 PsyPost20:14 12-Feb-25
 GlobeNewswire (Press Release)19:35 12-Feb-25
 TIME18:02 12-Feb-25
 Gizmodo16:56 12-Feb-25
 TCTMD15:57 12-Feb-25
 Pharmacy Times09:18 12-Feb-25
 Undark06:54 12-Feb-25
 Nature.com05:31 12-Feb-25
 The Good Men Project23:31 11-Feb-25
 Greek Reporter17:51 11-Feb-25
 Medpage Today15:36 11-Feb-25
 Drug Discovery & Development13:42 11-Feb-25
 British Medical Journal11:25 11-Feb-25
 Pharmaceutical Technology09:23 11-Feb-25
 The National Pulse09:01 11-Feb-25
 Pharmaceutical Technology05:50 11-Feb-25
 Barnsley Chronicle01:04 11-Feb-25
 Times LIVE21:32 10-Feb-25
 Stockhead14:19 10-Feb-25
 MailOnline11:46 10-Feb-25
 NewsMax08:34 10-Feb-25
 TheJournal.ie07:43 10-Feb-25
 Pharmaceutical Technology07:09 10-Feb-25
 MailOnline07:01 10-Feb-25
 HealthDay06:37 10-Feb-25
 Clinical Trials Arena06:17 10-Feb-25
 The Good Men Project19:03 8-Feb-25
 Business Wire (Press Release)14:01 8-Feb-25
 Knowridge Science Report05:37 8-Feb-25
 The Motley Fool03:59 8-Feb-25
 The Economic Times22:28 7-Feb-25
 News-Medical.Net21:19 7-Feb-25
 Pharmaceutical Technology14:43 7-Feb-25
 Pharmacy Times09:16 7-Feb-25
 pharmaphorum08:18 7-Feb-25
 University at Buffalo08:10 7-Feb-25
 Clinical Trials Arena06:44 7-Feb-25
 Scrip Pharma Intelligence18:39 6-Feb-25
 Pharmaceutical Technology14:50 6-Feb-25
 Nature.com12:50 6-Feb-25
 Invezz12:30 6-Feb-25
 HealthDay12:07 6-Feb-25
 Kiplinger.com11:25 6-Feb-25
 Wellbeing News10:48 6-Feb-25
 Zacks10:05 6-Feb-25
 Yahoo! US09:38 6-Feb-25
 Yahoo! US09:33 6-Feb-25
 Yahoo! US08:42 6-Feb-25
 ShareCast08:26 6-Feb-25
 Business Wire (Press Release)08:03 6-Feb-25
 Management in Practice07:42 6-Feb-25
 PR Newswire (Press Release)07:36 6-Feb-25

      
            
      
    view more headlines
   
      
      
      
21 Feb 21:01
   

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories